Cochrane is the only international organization that has the goal of synthesizing and keeping up to date the evidence for all of healthcare. Systematic reviews use explicit methods to identify, appraise, and synthesize available evidence for a clinical question. Cochrane Eyes and Vision (CEV) aims to prepare and promote access to systematic reviews of interventions used to prevent or treat eye conditions and/or visual impairment, and to help people adjust to visual impairment or blindness. For 17 years, CEV United States Satellite (CEV@US) has overseen production of systematic reviews contributing to eyes and vision comparative effectiveness research in the US in many ways. The purpose of comparative effectiveness research is to assist patients, clinicians, purchasers, and policy makers in making informed health decisions, and to contribute to evidence-based healthcare. Specifically, CEV@US aims to
Dr. Tianjing Li serves as the Director for CEV@US.
CEV@US Faculty, Staff and Students
Naira Khachatryan, MD, MPH, DrPH, is an Assistant Research Professor, Department of Ophthalmology, and the Project Director for Cochrane Eye and Vision US Satellite (CEV@US).
Dr. Khachatryan completed her ophthalmology training at the National Institute of Health of Armenia, and a doctorate in epidemiology and population health at the University of London, London School of Hygiene and Tropical Medicine. Her
research interests include clinical ophthalmology, ophthalmic epidemiology and health services research. Dr. Khachatryan’s most recent studies investigated racial and gender differences in glaucoma development and progression,
treatment outcomes of non-infectious uveitis, and vision-related quality of life.
Renee F. Wilson, MS, is a Research Associate at the Johns Hopkins University School of Public Health. She has been the Managing Editor for the Cochrane Eye and Vision US Satellite (CEV@US) since 2018. Additionally, she works with the Johns
Hopkins University Evidence-based Practice Center (EPC) as a Senior Research Program Manager. Prior to this she was the Managing Editor for the Journal of General Internal medicine for five years.
|Samuel Abariga, MD, MS, MPH, is a methodologist with the Cochrane Eye and Vision US Satellite (CEV@US). Dr. Abariga has several years of combined experience in patient care, clinical research, evidence synthesis, public health, and academia.
Prior to joining the CEV@US, he worked with various organizations in various capacities including: as research fellow in pharmacoepidemiology at the University of Maryland, Baltimore, where he conducted research in neuropsychiatric disturbances
and their management in the setting of traumatic brain injury; a methodologist with the Tufts medical center evidence review team where he was involved with evidence synthesis and clinical practice guidelines development; and in industry
as senior systematic reviewer with Evidera, a global contract research organization. He received his MD from the University of Science and Technology, Kumasi Ghana; a post-graduate diploma in Tropical Medicine from University of Liverpool
England; an MS in International Health Policy from Brandeis University; and an MPH from the University of Massachusetts, Amherst and is a Massachusetts Institute of Technology IMPACT fellow.|
Sueko Ng, MHS, is a methodologist with the Cochrane Eye and Vision US Satellite (CEV@US). Her role includes assisting the systematic review process, such as assessing the eligibility of relevant studies, critically appraising risk of bias,
extracting data, conducting qualitative and quantitative data synthesis, and preparing manuscripts for publication in The Cochrane Library. She received her Master of Health Science Degree from Johns Hopkins Bloomberg School of Public
Genie Han, MS, is a Senior Research Project Coordinator with the Cochrane Eye and Vision US Satellite (CEV@US). She has been involved with CEV@US since 2012. Ms. Han also serves as the coordinator for Consumers United for Evidence-based
Healthcare (CUE), a coalition of consumer health advocacy organizations in the United States.
E, MD, MPH, is a ScD candidate in the Department of Epidemiology at Johns
Hopkins Bloomberg School of Public Health. Jian-Yu received Master of Public
Health degree in epidemiology from Rutgers University School of Public Health.
His research interests include application of novel methods in systematic
reviews and clinical trials, assessing physiological declines and improving
well-being of people with vision impairments, and uncovering the intersection
of the physical activity and vison deterioration.
Riaz Qureshi, MSc, is a PhD Candidate at in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health. Riaz's academic background includes a Bachelor of Science in public health and a Master of Science in epidemiology and biostatistics from the universities of Waterloo and Western Ontario, respectively. Riaz's research focuses on the methods used to investigate harms of interventions at different levels of evidence: from adverse events collected and reported in clinical trials to the synthesis of harms in systematic reviews.
Lin Wang, MHS, is a PhD candidate in the Department of Epidemiology at Johns Hopkins University Bloomberg School of Public Health. Lin worked for China Food and Drug Administration (FDA, now named National Medical Products Administration) for four years as a medical reviewer and principal staff member. Lin’s academic background includes a ScM in Epidemiology from Johns Hopkins University Bloomberg School of Public Health and a MD from Central South University Xiangya School of Medicine.
Barbara S. Hawkins, MS, PhD, FSCT
Roberta Scherer, PhD, MA
Kirk Wilhelmus, MD, MPH, PhD